These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 17604563)

  • 1. Effects of alpha-lipoic acid supplementation in peripheral arterial disease: a pilot study.
    Vincent HK; Bourguignon CM; Vincent KR; Taylor AG
    J Altern Complement Med; 2007 Jun; 13(5):577-84. PubMed ID: 17604563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preliminary evidence that low ankle-brachial index is associated with reduced bilateral hip extensor strength and functional mobility in peripheral arterial disease.
    Parmenter BJ; Raymond J; Dinnen PJ; Lusby RJ; Fiatarone Singh MA
    J Vasc Surg; 2013 Apr; 57(4):963-973.e1. PubMed ID: 23246081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The vascular and biochemical effects of cilostazol in patients with peripheral arterial disease.
    O'Donnell ME; Badger SA; Sharif MA; Young IS; Lee B; Soong CV
    J Vasc Surg; 2009 May; 49(5):1226-34. PubMed ID: 19217745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upper- vs lower-limb aerobic exercise rehabilitation in patients with symptomatic peripheral arterial disease: a randomized controlled trial.
    Zwierska I; Walker RD; Choksy SA; Male JS; Pockley AG; Saxton JM
    J Vasc Surg; 2005 Dec; 42(6):1122-30. PubMed ID: 16376202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of a long-term exercise program on lower limb mobility, physiological responses, walking performance, and physical activity levels in patients with peripheral arterial disease.
    Crowther RG; Spinks WL; Leicht AS; Sangla K; Quigley F; Golledge J
    J Vasc Surg; 2008 Feb; 47(2):303-9. PubMed ID: 18241753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of relationship between gait parameters and physical function in peripheral arterial disease.
    Scherer SA; Hiatt WR; Regensteiner JG
    J Vasc Surg; 2006 Oct; 44(4):782-8. PubMed ID: 17012002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PoleStriding exercise and vitamin E for management of peripheral vascular disease.
    Collins EG; Edwin Langbein W; Orebaugh C; Bammert C; Hanson K; Reda D; Edwards LC; Littooy FN
    Med Sci Sports Exerc; 2003 Mar; 35(3):384-93. PubMed ID: 12618567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. D-dimer, inflammatory markers, and lower extremity functioning in patients with and without peripheral arterial disease.
    McDermott MM; Greenland P; Green D; Guralnik JM; Criqui MH; Liu K; Chan C; Pearce WH; Taylor L; Ridker PM; Schneider JR; Martin G; Rifai N; Quann M; Fornage M
    Circulation; 2003 Jul; 107(25):3191-8. PubMed ID: 12810614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoprotein apheresis in patients with peripheral artery disease and hyperlipoproteinemia(a).
    Poller WC; Dreger H; Morgera S; Berger A; Flessenkämper I; Enke-Melzer K
    Atheroscler Suppl; 2015 May; 18():187-93. PubMed ID: 25936325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of clinical attributes and treadmill walking performance in patients with claudication due to peripheral artery disease.
    Brass EP; Cooper LT; Hanson P; Hiatt WR
    J Vasc Surg; 2013 Aug; 58(2):396-403. PubMed ID: 23684414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid foot and calf compression increases walking distance in patients with intermittent claudication: results of a randomized study.
    Ramaswami G; D'Ayala M; Hollier LH; Deutsch R; McElhinney AJ
    J Vasc Surg; 2005 May; 41(5):794-801. PubMed ID: 15886663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving walking ability and ankle brachial pressure indices in symptomatic peripheral vascular disease with intermittent pneumatic foot compression: a prospective controlled study with one-year follow-up.
    Delis KT; Nicolaides AN; Wolfe JH; Stansby G
    J Vasc Surg; 2000 Apr; 31(4):650-61. PubMed ID: 10753272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Resveratrol on Walking Performance in Older People With Peripheral Artery Disease: The RESTORE Randomized Clinical Trial.
    McDermott MM; Leeuwenburgh C; Guralnik JM; Tian L; Sufit R; Zhao L; Criqui MH; Kibbe MR; Stein JH; Lloyd-Jones D; Anton SD; Polonsky TS; Gao Y; de Cabo R; Ferrucci L
    JAMA Cardiol; 2017 Aug; 2(8):902-907. PubMed ID: 28403379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Claudication distances and the Walking Impairment Questionnaire best describe the ambulatory limitations in patients with symptomatic peripheral arterial disease.
    Myers SA; Johanning JM; Stergiou N; Lynch TG; Longo GM; Pipinos II
    J Vasc Surg; 2008 Mar; 47(3):550-555. PubMed ID: 18207355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholesterol reduction with atorvastatin improves walking distance in patients with peripheral arterial disease.
    Mohler ER; Hiatt WR; Creager MA
    Circulation; 2003 Sep; 108(12):1481-6. PubMed ID: 12952839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of arm-ergometry versus treadmill exercise training to improve walking distance in patients with claudication.
    Treat-Jacobson D; Bronas UG; Leon AS
    Vasc Med; 2009 Aug; 14(3):203-13. PubMed ID: 19651669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of glutathione infusion on leg arterial circulation, cutaneous microcirculation, and pain-free walking distance in patients with peripheral obstructive arterial disease: a randomized, double-blind, placebo-controlled trial.
    Arosio E; De Marchi S; Zannoni M; Prior M; Lechi A
    Mayo Clin Proc; 2002 Aug; 77(8):754-9. PubMed ID: 12173710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The novel phosphodiesterase inhibitor NM-702 improves claudication-limited exercise performance in patients with peripheral arterial disease.
    Brass EP; Anthony R; Cobb FR; Koda I; Jiao J; Hiatt WR
    J Am Coll Cardiol; 2006 Dec; 48(12):2539-45. PubMed ID: 17174195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between temporal-spatial gait parameters, gait kinematics, walking performance, exercise capacity, and physical activity level in peripheral arterial disease.
    Crowther RG; Spinks WL; Leicht AS; Quigley F; Golledge J
    J Vasc Surg; 2007 Jun; 45(6):1172-8. PubMed ID: 17543681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results from a phase II multicenter, double-blind placebo-controlled study of Del-1 (VLTS-589) for intermittent claudication in subjects with peripheral arterial disease.
    Grossman PM; Mendelsohn F; Henry TD; Hermiller JB; Litt M; Saucedo JF; Weiss RJ; Kandzari DE; Kleiman N; Anderson RD; Gottlieb D; Karlsberg R; Snell J; Rocha-Singh K
    Am Heart J; 2007 May; 153(5):874-80. PubMed ID: 17452167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.